Acute bronchiolitis during the COVID-19 pandemic.
Enferm Infecc Microbiol Clin (Engl Ed)
; 40(10): 572-575, 2022 12.
Article
em En
| MEDLINE
| ID: mdl-36464475
ABSTRACT
INTRODUCTION:
The autumn and winter bronchiolitis epidemics have virtually disappeared in the first year of the COVID-19 pandemic. Our objectives were characterised bronchiolitis during fourth quarter of 2020 and the role played by SARS-CoV-2.METHODS:
Prospective multi-centre study performed in Madrid (Spain) between October and December 2020 including all children admitted with acute bronchiolitis. Clinical data were collected and multiplex PCR for respiratory viruses were performed.RESULTS:
Thirty-three patients were hospitalised with bronchiolitis during the study period 28 corresponded to rhinovirus (RV), 4 to SARS-CoV-2, and 1 had both types of infection. SAR-CoV-2 bronchiolitis were comparable to RV bronchiolitis except for a shorter hospital stay. A significant decrease in the admission rate for bronchiolitis was found and no RSV was isolated.CONCLUSION:
SARS-CoV-2 infection rarely causes acute bronchiolitis and it is not associated with a severe clinical course. During COVID-19 pandemic period there was a marked decrease in bronchiolitis cases.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bronquiolite
/
Infecções por Enterovirus
/
COVID-19
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limite:
Child
/
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article